Pfizer, BioNTech to Get $3.2 Billion From US in Vaccine Deal (1)

The US agreed to pay vaccine partners Pfizer Inc. and BioNTech SE $3.2 billion in a deal for 105 million of their messenger RNA shots against Covid-19.

The deal is for doses for adults, children and infants, and may include some shots that target the omicron variant, according to a statement from the companies. Deliveries are planned to begin as soon as late summer and continue into the fourth quarter. Payment will occur after the supply is delivered.

Pfizer shares rose 0.6% after US markets closed, while BioNTech’s American depositary receipts gained 1.4%.

The purchase of additional Covid supplies is ...